Archives
Archives by Date
2013: Mar2012: Jan Feb Mar Jul
2011: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2010: Jun Jul Aug Sep Oct Nov Dec
Archives by Category / Tag
- Archives
- Articles
- Settlements
- Tags
- 31 U.S.C. § 3730(c)(2)(A)
- AHA
- Allergan
- Allison Engine
- Allstate
- Almost Family
- Amedisys
- American Hospital Association
- Amgen
- Anti-Kickback Statute, 42 U.S.C. § 1320a-7b (AKS)
- BOTOX®
- Baxter
- Blackstone
- Boston Scientific
- Breach of Contract
- Buy American Act
- C.R. Bard
- CIDs
- California
- Celexa
- Certiorari
- Civil Investigative Demand
- ConAgra
- Construction
- Contractual Disputes
- Corporate Integrity Agreement (CIA)
- Data Mining
- Defense Contracts
- Dentists
- Deutsche bank
- Dodd-Frank Wall Street Reform and Consumer Protection Act
- Due Process
- Eighth Amendment
- Eighth Circuit
- Eleventh Amendment
- Ex Post Facto Clause
- Excessive Fines
- Express Certification
- FCA dismissals
- FCA enforcement trends
- FCA expansion
- FCA settlements
- FCA statistics
- FCA theories of liability
- FDA
- FOIA
- False Claims Act
- Federal Family Education Loan Program (FFELP)
- Fifth Circuit
- First Amendment
- First Circuit
- Fishing Expedition
- Floyd Landis
- Ford
- Forest Laboratories
- Fourth Circuit
- Fraud Enforcement and Recovery Act (FERA)
- General Dynamics
- Gentiva
- Government Knowledge
- Grand Jury Proceedings
- Guidant
- HEAT
- Home Health Care
- Illinois
- Implied Certification
- Indpendent Contractor
- Inpatient Rehabilitation Facilities (IRF)
- Insurance
- Iqbal
- Kickback
- Kyphon
- Kyphoplasty
- LHC Group
- Lance Armstrong
- Magace® ES
- Materiality
- McKesson
- MediNet
- Medicaid
- Medicaid rebate program
- Medicare
- Medicare Enrollment Application
- Medicare Payment Advisory Committee (MedPAC)
- Medicare Secondary Payer statute
- Medtronic
- Minnesota
- Misbranding
- Missouri
- N.Y. State Fin. Law § 188, et seq.
- New Jersey False Claims Act, N.J.S.A. 2A:32C-1 to -15 and N.J.S.A. 2A:32C-17 to -18
- New York
- New York Code of Professional Responsibility
- Ninth Circuit
- Novartis
- OIG
- Off-Label Marketing
- Office of Inspector General (OIG)
- Original Source
- Ortho Biotech
- PPACA
- Par
- Parallel Investigation
- Part B
- Patient Protection and Affordable Care Act (PPACA)
- Patient Referrals
- Penalties
- Pennsylvania
- Pfizer
- Physician Overpayments
- Place-Of-Service
- Presentment Clause
- Primary Insurer
- Public Disclosure
- Public Disclosure Bar
- Punitive Damages
- Rapamune
- Rebate Agreement
- Retroactive
- Reverse False Claim
- Rule 12(b)
- Rule 12(b)(1)
- Rule 12(b)(6)
- Rule 4.2
- Rule 8(a)
- Rule 9(b)
- Schindler Elevator
- Second Circuit
- Secondary Insurer
- Section 189(1)(b)
- Section 21F
- Securities & Exchange Commission (SEC)
- Senate Finance Committee
- Seventh Circuit
- Sixth Circuit
- State Farm
- Supreme Court
- Tax Fraud
- Tegress
- Tenth Circuit
- Texas
- Third Circuit
- Trade Agreements Act
- Twombly
- U.S. Department of Health & Human Services, Office of Inspector General (OIG)
- Under Seal
- United States Department of Agriculture (USDA)
- United States Postal Service
- VFATA
- Virginia Fraud Against Taxpayers Act (VFATA)
- Wyeth
- acquittal
- advice of counsel
- attorney-relator
- attorneys fees
- audit
- bankruptcy code
- bench trial
- cardiac defibrillators
- circuit split
- civil investigative demands
- collective knowledge
- common interest doctrine
- community property
- complaint-in-intervention
- compliance
- conditions of participation
- conditions of payment
- conference
- confidentiality agreement
- conflict of interest
- conspiracy
- criminal action
- damages
- defective
- defense contractor
- defense strategies
- device manufacturers
- discovery
- dismissal
- dismissals
- disqualification
- divorce
- doj
- drug companies
- drug manufacturers
- drugs
- expert testimony
- express false certification
- factual falsity
- factually false claims
- false certification
- falsity
- first-filed provision
- first-to-file bar
- government intervention
- grant application
- gsk
- hospital
- indiana
- indictment
- indirect reverse false claim
- intent
- intervention
- investigation
- investigatory law enforcement privilege
- kickbacks
- lauren stevens
- legal falsity
- legally false claims
- limited discovery
- lockheed martin
- medical device
- medical devices
- medical necessity
- mortgage fraud
- motion to compel
- motion to dismiss
- no-contact rule
- non-conforming goods
- nursing home
- obstruction
- overpayment
- plausibility
- pre & post FERA analysis
- pro se
- product defect
- products liability
- promissory fraud
- quality control
- quality of care
- qui tam award
- reasonable and necessary services
- referral fees
- relator-only action
- relator-only issues
- report
- retaliation
- retaliation claim
- retroactivity
- scienter
- seal
- self-reporting
- separation of powers
- settlement
- state FCA
- state false claims act
- statute of limitations
- strict liability
- student loan lenders
- student loans
- subject matter jurisdiction
- substantive defense
- summary judgment
- therapy visit
- work product privilege
- workers' compensation
- worthless services
